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H9N2 avian inﬂuenza virus circulates widely in poultry and has been responsible for sporadic human
infections in several regions. Few studies have been conducted on the pathogenicity of H9N2 AIV isolates
that have different genomic features. We compared the pathology induced by a novel reassortant H9N2
virus and two currently circulating H9N2 viruses that have different genomic features in ferrets. The
results showed that the three viruses can induce infections with various amounts of viral shedding in
ferrets. The novel H9N2 induced respiratory infection, but no pathological lesions were observed in lung
tissues. The other two viruses induced mild to intermediate pathological lesions in lung tissues, although
the clinical signs presented mildly in ferrets. The pathological lesions presented a diversity consistent
with viral replication in ferrets.
& 2015 Elsevier Inc. All rights reserved.Introduction
The threat posed by avian inﬂuenza A viruses (AIV) to humans
remains signiﬁcant because of sporadic avian-to-human trans-
missions, gene evolution and its potential for gene reassortment
with human viruses (Novel Swine-Origin Inﬂuenza et al., 2009).
H9N2 avian inﬂuenza virus is the most prevalent AIV in chicken
populations. At least ﬁfteen H9N2 human cases have been
reported in Hong Kong and South China since the late 1990s. In
addition, H9N2 AIV has presented interspecies transmission from
land-based poultry to swine, which were believed to be a “mixer”
of inﬂuenza viruses (Cong et al., 2007; Yu et al., 2011). These data
have increased concerns about the risk to human public health.
Avian H9N2 viruses have the potential to reassort with human
viruses, leading to improved pathogenicity. The virus has a classic
avian host range; however, many recent isolates contain a leucine
(L) instead of glutamine (Q) at position 226 in the receptor binding
site of the HA protein, which facilitates preferential binding to sialic
acid receptors in an α2,6 conformation (SAα2,6), typical of human
inﬂuenza viruses. L226-containing H9N2 viruses show efﬁcients to Dr. Yuelong Shu, 155
58900850.
.replication in human airway epithelial cells and in a ferret model
(Matrosovich et al., 2001; Wan and Perez, 2007; Wan et al., 2008).
Avian H9N2 viruses induce a mild ﬂu-like illness that can easily go
unreported. Seroepidemiological studies in Asia suggest that the
incidence of human H9N2 infections could be much more prevalent
than has been reported (Coman et al., 2013; Huang et al., 2013;
Pawar et al., 2012; Wang et al., 2009). In addition, previous studies
showed that H9N2 AIV is compatible with internal genes of the
2009 pandemic H1N1 and H3N2 viruses (Kimble et al., 2011; Sorrell
et al., 2009). Moreover, the reassortant H9N2 virus that contains the
internal genes of H1N1 or H3N2 virus can be transmitted via
respiratory droplets to create a clinical infection similar to human
inﬂuenza infections in the ferret model (Kimble et al., 2011; Sorrell
et al., 2009). Furthermore, a recent study indicated that the wide-
spread dissemination of H9N2 viruses poses a threat to human
health, not only because they have the potential to cause an inﬂu-
enza pandemic but also because they may function as vehicles to
deliver different subtypes of inﬂuenza viruses, such as H7N9 or
H10N8, from avian species to humans (Chen et al., 2014; Gao et al.,
2013; Li et al., 2014).
The viral isolates from human cases are phylogenetically mul-
tifarious, including the G1 and Y280 lineages (Dalby and Iqbal,
2014; Organization, 2015). Previous studies have shown that H9N2
AIV induces signiﬁcant pathological damage, including severe
bronchopneumonia in the airways of infected ferrets (Li et al.,
R. Gao et al. / Virology 488 (2016) 149–1551502014). However, the pathogenicity is obscure and is isolated to the
H9N2 AIVs that possess different genomic features. In this study,
we evaluated and compared the pathology caused by three H9N2
viruses containing different genomic features in ferrets.Fig. 2. The growth curve of the H9N2 viruses inoculated in MCDK. The MDCK
monolayers were inoculated at an MOI of 0.001, and the culture supernatants were
collected at the indicated time points and then titrated in MDCK cells. The error bar
represents the standard deviation.Results
Characterization of the H9N2 viruses used for ferret infection
To characterize the variety of H9N2 viruses, the full genomic
sequences of the three H9N2 viruses were compared to the other
H9N2 viral sequences deposited in GenBank. The BLAST search
results suggested that, except for SC11, the 8 segments of the other
two viruses were closely related to H9N2 or H7N9 (PA segment of
HN11197) avian inﬂuenza viruses, with sequence homologies
ranging from 97% to 99% (Supplemental Table 1). Except for the HA
gene, the other seven segments of SC11 were most closely related
to variant non-H9N2 subtype viruses with 97–99% identity (Sup-
plemental Table 1). Phylogenetic analysis revealed that the HA and
NA genes of the JX02898 and HN11197 viruses were clustered in
the Y280 clade, the HA gene of SC11 belonged to the G1 clade, and
the NA gene of SC11 were clustered with the H5N2 or H3N2
viruses (Fig. 1). The internal genes of JX02898 and HN11197 were
clustered in the G1 (PB2 and M) or F-98 (PA, PB1, M and NS) clades,
as published in a previous study (Sun et al., 2010) (Supplemental
Fig. 1). Within the receptor binding site, the HA proteins contain
amino acid residues consistent with binding to human-like SA-2,6
receptors (L226/G228) in JX02898 and HN11197, or (L226/Q228) in
SC11. A 3-amino-acid deletion at the NA stalk was present in the
JX02898 and HN11197 viruses, but not in the SC11 virus. No
mutations associated with increased virulence in mammals were
found in the PB2, PB1, or NS proteins. Analysis of the neur-
aminidase active and framework sites of the NA protein revealed
various amino acid residues on 3 loops that directly interact with
sialic acid for the hemabsorbing (HB) function of the three viruses
(Supplemental Table 2). Of note, only one human isolate (A/Hon-
g_Kong/1073/99) besides HN11197 and a few bird isolates A/chicken/Shanghai/1107/2013 | A / H9N2 | HA
 A/chicken/Zhejiang/C497/2013 | A / H9N2 | HA
 A/Hong Kong/308/2014 | A / H9N2 | HA*
 A/wild chicken/Shanghai/C1/2014 | A / H9N2 | HA
 A/turtledove/Guangxi/49B6/2013 | A / H9N2 | HA
 A/environment/Guangdong/02818/2012
 A/chicken/Guangxi/LS/2013 | A / H9N2 | HA
 A/environment/Jiangxi/02898/2012
 A/hunanlengshuitan/11197/2013*
 A/muscovy duck/Vietnam/LBM694/2014 | A / H9N2 | HA
 A/chicken/Long An/63/2014 | A / H9N2 | HA
 A/chicken/Shanghai/D/2011 | A / H9N2 | HA
 A/Hong Kong/3239/2008*
 A/Nanchang/CH2/2000*
 A/Duck/Hong Kong/Y280/97 | A / H9N2 | HA
 A/chicken/Shanghai/B/2010 | A / H9N2 | HA
 A/Shantou/239/98*
 A/Chicken/Shanghai/F/98 | A / H9N2 | HA
 A/HK/2108/2003*
 A/chicken/Beijing/1/1994 | A / H9N2 | HA
 A/Hong Kong/1074/1997*
 A/Hong Kong/33982/2009*
 A/Hong Kong/1073/99*
 A/Quail/Hong Kong/G1/97 | A / H9N2 | HA
 A/Bangladesh/0994/2011*
 A/environment/Bangladesh/20199/2013 | A / H9N2 | HA
 A/Korea/KBNP-0028/2000*
 A/Duck/Hong Kong/Y439/97 | A / H9N2 | HA
 A/mallard/Switzerland/WV1070805/2007(H9N2)
 A/mallard/Austria/WV1090234/2007(H9N2)
 A/mallard/Iran/T370/2007(H9N2)
 A/mallard/Iran/C370/2007(H9N2)
 A/mallard/Iran/C364/2007(H9N2)
 A/gadwall/Netherlands/1/2006(H9N2)
 A/baikal teal/Xianghai/421/2011(H9N2)
 A/duck/Hokkaido/238/2008(H9N2)
 A/environment/Sichuan/11/2010
0.02
G1-like
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like
Fig. 1. Phylogenetic analysis of the HA (A) and NA (B) genes of H9N2 viruses. The H9N
marked with asterisks. The evolutionary distances were calculated using the maximum
stitutions per site.containing a 369G in sequences were deposited in the GeneBank
database (data not shown). The growth of all three H9N2 viruses
was comparable on MDCK cells (Fig. 2). Viral replication reached a
peak in MDCK cells inoculated with each of the three viruses at
48 h pi. The titers of SC11 were signiﬁcantly lower than the other
two viruses at 24 h pi (po0.05); however, HN11197 and SC11 had
higher titers than JX2898 at 48 h and 96 h pi (po0.05).
Infection and clinical signs after the inoculation of ferrets
None of the inoculated ferrets demonstrated differences in
body weight compared to the control animal (Fig. 3), and no
changes in food consumption or behavior were observed. No
animal presented with the symptom of sneezing. However, a rise
in body temperature was noted. The highest body temperature
(40.3 °C) was observed at 3 dpi in one animal inoculated with
HN11197. The largest elevations in body temperature were present A/Hong Kong/308/2014 | A / H9N2 | NA*
 A/hunanlengshuitan/11197/2013*
 A/turtledove/Guangxi/49B6/2013 | A / H9N2 | NA
 A/wild chicken/Shanghai/C1/2014 | A / H9N2 | NA
 A/chicken/Shanghai/1107/2013 | A / H9N2 | NA
 A/chicken/Zhejiang/C497/2013 | A / H9N2 | NA
 A/environment/Jiangxi/02898/2012
 A/chicken/Shanghai/D/2011 | A / H9N2 | NA
 A/environment/Guangdong/02818/2012
 A/chicken/Shanghai/B/2010 | A / H9N2 | NA
 A/Duck/Hong Kong/Y280/97 | A / H9N2 | NA
 A/Nanchang/CH2/2000 | A / H9N2 | NA*
 A/Chicken/Shanghai/F/98 | A / H9N2 | NA
 A/chicken/Beijing/1/1994 | A / H9N2 | NA
 A/Shantou/239/98 | A / H9N2 | NA*
 A/Guangzhou/333/99 | A / H9N2 | NA*
 A/HK/2108/2003 | A / H9N2 | NA*
 A/Hong Kong/33982/2009 | A / H9N2 | NA*
 A/Hong Kong/3239/2008 | A / H9N2 | NA*
 A/chicken/Guangxi/LS/2013 | A / H9N2 | NA
 A/muscovy duck/Vietnam/LBM694/2014 | A / H9N2 | NA
 A/chicken/Long An/63/2014 | A / H9N2 | NA
 A/Hong Kong/1073/99 | A / H9N2 | NA*
 A/Quail/Hong Kong/G1/97 | A / H9N2 | NA
 A/Hong Kong/1074/1997 | A / H9N2 | NA*
 A/Bangladesh/0994/2011 | A / H9N2 | NA*
 A/environment/Bangladesh/20199/2013 | A / H9N2 | NA
 A/Duck/Hong Kong/Y439/97 | A / H9N2 | NA
 A/Korea/KBNP-0028/2000 | A / H9N2 | NA*
 A/avian/Japan/8KI0148/2008(H4N2)
 A/wild bird/Korea/A81/2009(H5N2)
 A/duck/Japan/9UO025/2009(H5N2)
 A/duck/Korea/A93/2008(H5N2)
 A/environment/Sichuan/11/2010
 A/duck/Mongolia/OIE-7799/2011(H3N2)
 A/spot-billed duck/Xianghai/427/2011(H5N2)
 A/duck/Korea/A14/2008(H5N2)
 A/duck/Korea/SH0915/2009(H9N2)
 A/chicken/Korea/KNUSWR09/2009(H9N2)
 A/chicken/Korea/A146/2009(H9N2)
 A/chicken/Korea/KNUWSJ09/2009(H9N2)
 A/chicken/Korea/A170/2009(H9N2)
0.02
-
G1- like
Y280-
like
Eurasian
2 viruses used in this study are marked with a solid triangle. Human isolates are
likelihood method. The scale bar at the bottom of each tree indicates the sub-
Fig. 3. Ferret weight changes after inoculation with H9N2 viruses. The results for the three infected ferrets for each virus treatment group are shown (ferrets 1, 2 and 3). One
ferret was set as the control (control ferret) for comparison. H9N2 infected groups: HN11197 (A), JX2898 (B), and SC11 (C).
Table 1
Clinical signs and seroconversion in ferrets inoculated with H9N2 isolates.
Virus Clinical signs Serum
Sneezing
(day of
onset)
Running nose
(initial day of
onset)
Running nose
(last day of
onset)
HN11197 0/4 3/3 (2, 3, 2) 3/3 (6, 9, 9) ≧2560,
≧2560,
≧2560
JX2898 0/4 3/3 (2, 2, 4) 3/3 (8, 6, 9) 1280, ≧2560,
≧2560
SC11 0/4 3/3 (3, 2, 2) 3/3 (3, 9, 3) 40, 40, 40
Fig. 4. Viral shedding in the upper respiratory tracts of ferrets inoculated with the
H9N2 avian inﬂuenza virus. Groups of three ferrets were intranasally inoculated
with a dose of 106 TCID50. Nasal washes were harvested from each inoculated
ferret at 1, 3, 5, 6 and 9 dpi and titrated with a TCID50 on MDCK cells. The limit of
detection was 102 TCID50/ml. npo0.05 or nnpo0.01 compared between HN1197
and JX2898.
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body temperature of 1.43 °C), then at 7 dpi in animals inoculated
with JX2898 (mean increase in body temperature: 1.33 °C) and
1 dpi for those inoculated with JX2898 (mean increase in body
temperature: 0.67 °C). The mean duration of a running nose was
8 days in the animals inoculated with HN11197, 7.7 days with
JX2898, and 5 days with SC11 (Table 1).
Virus shedding from each of the inoculated ferrets except for
those animals sacriﬁced at day 3 pi was detected in nasal washes
from days 1 to 9 pi. Viral shedding peaked at 5 dpi (6.170.57 log
TCID50/ml) or 7 dpi (5.5770.02 log TCID50/ml) in ferrets infected
with HN11197 or JX2898, respectively (Fig. 4A). In addition, all of
the experimental ferrets in the two groups seroconverted, with HItiters ranging from 1280 to over 2560 (Table 1). By day 9 pi, virus
was undetectable in nasal washes from all of the tested ferrets. In
contrast, the viral titers were less than 2 log TCID50/ml in all of the
nasal washes collected from the SC11-inoculated ferrets, although
RT-PCR yielded positive results in those samples collected at 3 dpi
(PCR positive in 2 out of 3 inoculated animals, with Ct values of
33.56 and 35.53) or 5 dpi (PCR positive in all 3 inoculated animals,
with Ct values of 32.93, 33.84 and 35.83). Consistent with the RT-
PCR results and clinical signs, the sera from ferrets inoculated with
SC11 had 4-fold increased seroconverted HI antibody (Table 1).Histopathology assessment
To determine if infection by different H9N2 viruses resulted in
pathological injuries, tissues from the ferrets sacriﬁced on day 3 pi
underwent a histological evaluation. Gross lesions were apparent in
the lungs of HN1119- and JX2898-infected ferrets, but not those
infected with SC11, at the time of necropsy (Fig. 5A, E and I). Fig. 5H
and E staining revealed slight tracheitis and interstitial bronchial
pneumonia in HN1119- and JX2898-inoculated ferrets, but not in
the SC11 group. Histologically, tracheitis manifested a focal denu-
dation of the epithelium and submucosal edema with sparse
inﬂammatory inﬁltrates, and interstitial bronchial pneumonia
manifested as occasional foci of alveolar septal necrosis, multifocal
hemorrhage, and alveolar hyaline membranes. The lesions were
moderate in HN11197 infection and mild with JX2898 (Fig. 5A–H).
No histological lesions related to the experimental infection were
observed in the lungs or trachea of ferrets inoculated with SC11
(Fig. 5I–L), while mild rhinitis was presented in SC11-inoculated
ferrets. Histologically, rhinitis manifested as an expansion of the
mucosa with edema and congestion and inﬁltration with inﬂam-
matory cells in the nasal turbinates (Fig. 5Q and R). In addition,
lymphoid hyperplasia was observed in the spleen from ferrets
inoculated with HN11197 or JX2898, but not with SC11. No speciﬁc
lesions were observed in other tissues, including the liver, intestines
and heart, from the H9N2-inoculated ferrets, although inﬂuenza A
PCR was positive for intestinal tissues from HN11197- or JX2898-
inoculated ferrets, but not for SC11 (Table 2).
By comparison, the respiratory lesions of ferrets inoculated
with HN11197 were much more severe and more extensive than
those of ferrets inoculated with JX2898. The lesions were con-
sistent with viral titers in the harvested tissues (Fig. 5S). The viral
shedding was higher in upper (turbinate) and lower (trachea and
lung) respiratory tissues from HN11197 than from JX2898. No
remarkable lesions were observed in the respiratory tissues,
except the nasal turbinates, from SC11-inoculated ferrets, and no
viral shedding (log TCID50o2) was detected in any tissues.
Fig. 5. Histopathology in the respiratory tissues and viral shedding in the respiratory tissues and intestines of ferrets. The gross features show multifocal reddish con-
solidated areas of acute inﬂammation in the lungs (arrow) of HN11197- (A) or JX2898 (E)-inoculated ferrets at 3 dpi, but not in those of SC11 (I) or control (M) animals.
Micrograph depicting severe tracheitis characterized by edema and congestion of mucosa, inﬁltration of neutrophils and desquamated epithelial cell remnants in the
tracheal tissues (arrow) of an HN11197-inoculated ferret (B); moderate bronchitis characterized by congestion and edema of the submucosa, and inﬁltration of neutrophils in
the lungs (arrow) (C); and moderate alveolar damage characterized by thickened septa, congestion and inﬁltration of neutrophils in the lungs (arrow) (D). In JX2898-
inoculated ferrets, mild tracheitis with congestion and focal inﬁltration of neutrophils in the mucosa (F) (arrow), and mild alveolar damage with thickened alveolar septa is
shown adjacent to a bronchus containing a plug of mucus with few neutrophils and desquamated epithelial cell remnants (G, H) (arrow). No speciﬁc lesion is observable in
the trachea and lungs from SC11-inoculated ferrets (J, L) or the control ferret (N, O, P). Mild lymphocytic bronchiolitis with slight intra-luminal cellular debris is visible in the
bronchus of SC11-inoculated ferrets (K). Mild to moderate rhinitis, characterized by edematous mucosa and multiple neutrophils or desquamated epithelial cell remnants
(arrow), can be seen in turbinates from SC11- (Q) or HN11197- (R) inoculated ferrets. The viral shedding in harvested tissues is visualized by TCID50 in MDCK cells (S).
R. Gao et al. / Virology 488 (2016) 149–155152Discussion
H9N2 viruses reassort from the current permanent H9N2
lineages and other inﬂuenza subtypes infrequently, although
intra-lineage viral reassortments occur frequently (Dalby and
Iqbal, 2014; Fusaro et al., 2011). Our study reported a novel reas-
sorted H9N2 virus, SC11, with a 7þ1 genomic composition (HA
from the H9N2 virus, the other segments from non-H9N2 subtype
viruses). SC11 replicated well in MDCK cells with later initiationkinetics compared to HN11197 or JX2898 and induced mild clinical
signs and slight upper respiratory damage with undetectable viral
shedding in a ferret model. Comparably, the human isolate
HN11197 replicated better in ferrets than the environmental iso-
late JX2898. Sequence analysis showed that HN11197 contains a
signiﬁcant difference from JX2898 at the HB site 366–373
(Table 1). A previous study suggested that the NA protein did not
affect virus replication kinetics, but affected the initiation of
infection, virus release and fusion of infected cells, which may be
Table 2
Histopathology and PCR detection results of tissues harvested from ferrets inocu-
lated with H9N2 isolates.
Organs HN11197 JX2898 SC11
Histology PCR
(Ct
value)
Histology PCR
(Ct
value)
Histology PCR (Ct
value)
Trachea Tracheitis 27.42 Tracheitis No Ct – No Ct
Lung Broncho
pneumonia
19.98 Broncho
pneumonia
30.7 – No Ct
Nasal Turbinates NSa 20.08 NS 32.74 Rhinitis 30.56
Heart –b No Ct – No Ct – No Ct
Intestines – 29.39 – 26.52 – No Ct
Liver – No Ct – No Ct – No Ct
Spleen Lymphoid
hyperplasia
No Ct Lymphoid
hyperplasia
No Ct – No Ct
a No enough samples for histopathology assay.
b No histopaghological lesion.
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and 6-sialylated carbohydrate chains (Chen et al., 2013). Addi-
tionally, the S368N change may abolish the activity of NA (Air and
Laver, 1995). Of note, the HB site described earlier is common for
the NAs of viruses in which HA interacts with α-2, 3-sialylated
carbohydrate chains (i.e., avian or equine inﬂuenza viruses).
Moreover, the key amino acid positions of this site are changed in
viruses with α-2,6-speciﬁcity (human, swine, and poultry H9N2
viruses) (Shtyrya et al., 2009).
Additionally, previous studies revealed that L226-containing
H9N2 viruses exhibit human virus-like receptor speciﬁcity (Abdel-
Moneim et al., 2012; Matrosovich et al., 2001; Wan and Perez,
2007). Further evidence showed that H9N2 viruses with Leu226
can replicate in ferrets and can be transmitted between individuals
by direct contact or respiratory droplets, indicating a potential
threat to humans (Li et al., 2014; Wan et al., 2008). In this study, all
of the involved H9N2 viruses contain L226. However, the novel
reassorted virus SC11 cannot replicate well in ferrets, although the
virus led infection in ferrets, as evidenced by the serological
results or the clinical signs. The results suggest that ferrets are not
susceptible to the novel H9N2 virus SC11. In contrast, high viral
shedding was detected in the upper respiratory tracts of HN11197-
or JX2898-inoculated ferrets and in the lungs of HN11197-
inoculated ferrets. Of note, the sequence analysis showed that
only two human isolates anda few bird isolates are known to
contain 369G in NA HB sites to date (data not shown). However,
previous studies suggested that the substitution of HB sites serves
to enhance the catalytic efﬁciency of NA and may increase viral
replication (Ohuchi et al., 1995; Suzuki et al., 2005; Uhlendorff et
al., 2009). Thus, the mutation in the NA HB sites may signify a need
for further study because this alteration is needed for the emer-
gence of pandemic inﬂuenza viruses in addition to changes in the
receptor-binding speciﬁcity of the hemagglutinin.
Ferrets are an optimal animal model for studying inﬂuenza
disease pathogenesis because inﬂuenza infection in ferrets closely
mimics that in humans with respect to the clinical signs, patho-
genesis and antibody responses (Maher and DeStefano, 2004). All
of the reported H9N2 human cases in the world so far have been
mild cases, and no viral pneumonia has presented in these cases.
In contrast, our results showed that both human virus HN11197
and environmental virus JX2898 can induced mild to moderate
bronchopneumonia in ferrets, and the pathological lesions were
consistent with viral shedding. However, the viruses only induced
a mild disease in the infected ferrets. Previous studies have shown
that the immune status of the host is a factor in pathogenicity and
that the severity of disease could be related to a less effectiveinnate and adaptive immune response in some inﬂuenza infec-
tions (Bermejo-Martin et al., 2010; Sun and Braciale, 2013). In
ferrets, very high levels of serum antibodies were produced after
inoculation with a low dose of H9N2 virus, which perhaps
accounts for the modest severity of the observed disease. In other
words, the virus may induce a severe infection in immunosup-
pressed people because impaired adaptive immunity leaded to an
unremitting cycle of viral replication and innate cytokine–che-
mokine release (Bermejo-Martin et al., 2010). Animal model also
showed that inﬂuenza virus may cause more severe morbidity
with high cytokine/chemokine production by the host innate
immune system in macaques under an immunosuppressive con-
dition than that seen in macaques under the immunocompetent
condition (Pham et al., 2013).
In conclusion, we reported a novel reassortant H9N2 virus and
compared the pathological features induced by H9N2 viruses
containing different genomic features. The novel H9N2 can induce
mild infection in ferrets. Pathologically, H9N2 infections can result
in mild to moderate lesions in lung tissue, although the clinical
signs presented mildly in ferrets. The mechanism for this phe-
nomenon requires further study.Materials and methods
The virus
Three lowly pathogenic avian inﬂuenza A (H9N2) viruses, A/
Hunanlengshuitan/11197/2013 (HN11197), A/environment/Sichuan/
11/2010 (SC11) and A/environment/Jiangxi/02898/2012 (JX02898),
were used in this study. Of these viruses, HN11197 was isolated
from a recently reported inﬂuenza-like illness case (Huang et al.,
2015). The virus was submitted to the Chinese National Inﬂuenza
Center according to the Chinese surveillance guidelines for avian
inﬂuenza viruses. The other two viruses were isolated from envir-
onmental samples collected from live poultry markets in Sichuan
and Jiangxi provinces. The environmental sample collection was
conducted according the Chinese surveillance guidelines for avian
inﬂuenza viruses. The virus was propagated in 10-day-old
embryonated chicken eggs and was incubated at 37 °C for 48 h.
Genome sequencing and phylogenetic analysis
Genome sequencing was conducted according our previous
report (Gao et al., 2013). Brieﬂy, the full genome of the virus was
ampliﬁed with the use of the Qiagen OneStep RT-PCR Kit for
sequencing. PCR products were puriﬁed from an agarose gel with
the use of the QIAquick Gel Extraction Kit (Qiagen, Germany). We
performed sequencing using an ABI 3730xl automatic DNA ana-
lyzer (Life Technologies, USA) and the ABI BigDye Terminator v3.1
cycle sequencing kit (Life Technologies, USA), according to the
manufacturer's recommendations. Full genome sequences of the
viruses were deposited in the Global Initiative on Sharing Avian
Inﬂuenza Data (GISAID) database (Accession no. EPI-ISL192894-
192895). Phylogenetic analysis was conducted with MEGA5.1
using the maximum likelihood tree.
Viral titration
The H9N2 viruses were titrated by a TCID50 (50% tissue culture
infectious dose) in MDCK cells. Brieﬂy, 100 μl/well of MDCK cells
(3104 cells/ml) was seeded one day before infection in 96-well
microtiter plates. Serial semi-logarithmic dilutions of each virus or
samples were made with DMEM containing 1% BSA and 2 μg/mL
TPCK-treated trypsin from 102 to 107. Dilutions of each virus or
sample were added to MDCK cells (4 wells for each dilution,
R. Gao et al. / Virology 488 (2016) 149–155154100 μl/well). The cells were incubated for 48 h at 37 °C. The con-
tents of each well were tested for hemagglutination by incubating
50 μl of the tissue culture supernatant with 0.5% turkey ery-
throcytes. The TCID50 was calculated according to the Reed and
Meunch method. For tissue processing, in brief, 200 μg of tissue
from different lobes was homogenized in 2 ml of PBS. The super-
natant was sampled after centrifugation at 3000 rpm for 15 min
at 4 °C.
Viral growth kinetics in MDCK cells
To determine the virus growth capacity in vitro, 0.001 MOI
H9N2 viruses were seeded on MDCK cells (400 μl/well) in 24-well
microtiter plates and were incubated with DMEM containing 1%
BSA and 2 μg/mL TPCK-treated trypsin at 37 °C. The cell super-
natants were harvested at 6-h, 24-h, 48-h, 72-h and 96-h post-
inoculation (pi) for TCID50 titrations. Four wells were sampled at
each time point.
Pathogenicity in ferrets
All animal studies were performed according to guidelines
approved by the Investigational Animal Care and Use Committee
of the National Institute for Viral Diseases Control and Prevention
of the China CDC. The ferret infection tests were carried out as
described previously (Wan et al., 2008). All studies were con-
ducted in a Biosafety Level 2þ facility. Six-to-eight-month-old
male ferrets were used in this study. Prior to infection, the ferrets
were housed in individual ventilation cages. A subcutaneous
implantable temperature transponder (Bio Medic Data Systems,
Seaford, DE) was placed in each ferret to acquire temperature
readings. Three days before infection, blood was collected from
each animal. The collected sera were tested for antibodies against
H9N2 and seasonal inﬂuenza viruses using a hemagglutination
inhibition (HI) assay. Ferrets with HI titers lower than 20 were
considered inﬂuenza A-free and were used in this study. Each
infection group consisted of four ferrets. The ferrets were inocu-
lated intranasally with 106 TCID50 of virus in PBS after being
lightly anesthetized with 0.1 ml of Serra hydrochloride sumianxin
II (Shengda Animal Medicine Ltd., China) by an intramuscular
injection. To qualify the infection experiment, one ferret was
established as the control and was inoculated with phosphate-
buffered saline (PBS). The animals' clinical signs and temperatures
were recorded daily. To monitor viral shedding, nasal washes were
collected into Petri dishes by instilling 1.5 ml of PBS into the
nostrils on 1 day, 3 days, 5 days, 7 days and 9 days pi. Samples
were stored at 80 °C for further study. For each infection group,
one ferret was sacriﬁced for a pathological evaluation or virus
titration of the tissues at day 3 pi. At day 22 pi, blood was collected
for the H9N2 seroconversion HI antibody assay.
Histopathological evaluation
Histological evaluation was conducted on the nasal turbinate,
trachea, lung, heart, liver, spleen and intestines harvested from
sacriﬁced animals. Those tissues were ﬁxed with 10% buffered
formalin and then were embedded in parafﬁn wax. Routine
hematoxylin and eosin (H and E) staining was conducted on 4–5-
μm thick deparafﬁnized sections to detect lesions consistent with
viral infection.
Real-time RT-PCR
Real-time RT-PCR was conducted to detect viruses in the har-
vested tissues and nasal washes. RNA was extracted from the tis-
sue homogenates or nasal washes using the QIAamp Viral RNAMini Kit (QIAGEN, Inc., Valencia, CA) according the manufacturer's
recommended protocol. Real-time RT-PCR was performed with an
AgPath one-step RT-PCR kit (Applied Biosystems, Inc. Foster, CA)
and a Stratagene detection system (Agilent Technologies, Inc.,
Santa Clara, CA) using a ﬂuorescently labeled TaqMan probe to
enable continuous monitoring of amplicon formation. The primer
and probe set targeted for inﬂuenza A virus M gene, and reaction
condition followed our previous report (Gao et al., 2011). Controls
were set using the virus RNA stocks with a Ct value of 30–33. A
sample was considered positive for inﬂuenza A if the Ct value was
less than 38.
Hemagglutination-inhibition (HI) assay
Prior to testing by the HI assay with turkey RBC, the serum
samples were treated with 4-fold dilutions of receptor destroying
enzyme (RDE) at 37 °C for 18 h, followed by incubation at 56 °C for
30 min. The serum samples were titrated in 2-fold dilutions of PBS
and tested at an initial dilution of 1:10. Virus was added at a
concentration of 4 HAU/25 μL.
Statistical method
The viral replication titers were compared for the different
H9N2 viruses. Statistical signiﬁcance was determined by non-
parametric t-tests using Graph (Vision 5.0, GraphPad Prism). Dif-
ferences were considered signiﬁcant at po0.05 with two-tailed
testing.Acknowledgments
The authors would like to thank the Chinese National Inﬂuenza
Surveillance Network for the collection of environmental samples
and the identiﬁcation of H9N2 human cases. This study was sup-
ported by the National Natural Science Foundation of China
(81373107 to Dr. Rongbao Gao), the Young Scholar Scientiﬁc
Researcher Foundation of China CDC (No. 2015A 101 to Dr. Rong-
bao Gao) and the National Mega-Projects for Infectious Diseases
(2014ZX10004002 to Dr. Yuelong Shu).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2015.11.013.References
Abdel-Moneim, A.S., Aﬁﬁ, M.A., El-Kady, M.F., 2012. Isolation and mutation trend
analysis of inﬂuenza A virus subtype H9N2 in Egypt. Virol. J. 9, 173.
Air, G.M., Laver, W.G., 1995. Red cells bound to inﬂuenza virus N9 neuraminidase
are not released by the N9 neuraminidase activity. Virology 211, 278–284.
Bermejo-Martin, J.F., Martin-Loeches, I., Rello, J., Anton, A., Almansa, R., Xu, L.,
Lopez-Campos, G., Pumarola, T., Ran, L., Ramirez, P., Banner, D., Ng, D.C., Socias,
L., Loza, A., Andaluz, D., Maravi, E., Gomez-Sanchez, M.J., Gordon, M., Gallegos,
M.C., Fernandez, V., Aldunate, S., Leon, C., Merino, P., Blanco, J., Martin-Sanchez,
F., Rico, L., Varillas, D., Iglesias, V., Marcos, M.A., Gandia, F., Bobillo, F., Nogueira,
B., Rojo, S., Resino, S., Castro, C., Ortiz de Lejarazu, R., Kelvin, D., 2010. Host
adaptive immunity deﬁciency in severe pandemic inﬂuenza. Crit. Care 14, R167.
Chen, H., Yuan, H., Gao, R., Zhang, J., Wang, D., Xiong, Y., Fan, G., Yang, F., Li, X., Zhou,
J., Zou, S., Yang, L., Chen, T., Dong, L., Bo, H., Zhao, X., Zhang, Y., Lan, Y., Bai, T.,
Dong, J., Li, Q., Wang, S., Zhang, Y., Li, H., Gong, T., Shi, Y., Ni, X., Li, J., Zhou, J., Fan,
J., Wu, J., Zhou, X., Hu, M., Wan, J., Yang, W., Li, D., Wu, G., Feng, Z., Gao, G.F.,
Wang, Y., Jin, Q., Liu, M., Shu, Y., 2014. Clinical and epidemiological character-
istics of a fatal case of avian inﬂuenza A H10N8 virus infection: a descriptive
study. Lancet 383, 714–721.
R. Gao et al. / Virology 488 (2016) 149–155 155Chen, Q., Huang, S., Chen, J., Zhang, S., Chen, Z., 2013. NA proteins of inﬂuenza A
viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection
initiation, virus release, and cell–cell fusion. PLoS One 8, e54334.
Coman, A., Maftei, D.N., Krueger, W.S., Heil, G.L., Friary, J.A., Chereches, R.M., Sir-
lincan, E., Bria, P., Dragnea, C., Kasler, I., Gray, G.C., 2013. Serological evidence
for avian H9N2 inﬂuenza virus infections among Romanian agriculture work-
ers. J. Infect. Public Health 6, 438–447.
Cong, Y.L., Pu, J., Liu, Q.F., Wang, S., Zhang, G.Z., Zhang, X.L., Fan, W.X., Brown, E.G.,
Liu, J.H., 2007. Antigenic and genetic characterization of H9N2 swine inﬂuenza
viruses in China. J. Gen. Virol. 88, 2035–2041.
Dalby, A.R., Iqbal, M., 2014. A global phylogenetic analysis in order to determine the
host species and geography dependent features present in the evolution of
avian H9N2 inﬂuenza hemagglutinin. PeerJ 2, e655.
Fusaro, A., Monne, I., Salviato, A., Valastro, V., Schivo, A., Amarin, N.M., Gonzalez, C.,
Ismail, M.M., Al-Ankari, A.R., Al-Blowi, M.H., Khan, O.A., Maken Ali, A.S.,
Hedayati, A., Garcia Garcia, J., Ziay, G.M., Shoushtari, A., Al Qahtani, K.N., Capua,
I., Holmes, E.C., Cattoli, G., 2011. Phylogeography and evolutionary history of
reassortant H9N2 viruses with potential human health implications. J. Virol. 85,
8413–8421.
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., Xu,
X., Lu, H., Zhu, W., Gao, Z., Xiang, N., Shen, Y., He, Z., Gu, Y., Zhang, Z., Yang, Y.,
Zhao, X., Zhou, L., Li, X., Zou, S., Zhang, Y., Li, X., Yang, L., Guo, J., Dong, J., Li, Q.,
Dong, L., Zhu, Y., Bai, T., Wang, S., Hao, P., Yang, W., Zhang, Y., Han, J., Yu, H., Li,
D., Gao, G.F., Wu, G., Wang, Y., Yuan, Z., Shu, Y., 2013. Human infection with a
novel avian-origin inﬂuenza A (H7N9) virus. N. Engl. J. Med. 368, 1888–1897.
Gao, R., Wang, D., Wen, L., Li, X., Wang, W., Zhao, X., Zeng, Y., Xin, L., Lan, Y., Zhang,
Y., Shu, Y., 2011. Development of the real-time RT-PCR detection system for
determination of pandemic inﬂuenza A (H1N1) virus. Acta Virol. 55, 85–87.
Huang, R., Wang, A.R., Liu, Z.H., Liang, W., Li, X.X., Tang, Y.J., Miao, Z.M., Chai, T.J.,
2013. Seroprevalence of avian inﬂuenza H9N2 among poultry workers in
Shandong Province, China. Eur. J. Clin. Microbiol. Infect. Dis.: Off. Publ. Eur. 32,
1347–1351.
Huang, Y., Li, X., Zhang, H., Chen, B., Jiang, Y., Yang, L., Zhu, W., Hu, S., Zhou, S., Tang,
Y., Xiang, X., Li, F., Li, W., Gao, L., 2015. Human infection with an avian inﬂuenza
A (H9N2) virus in the middle region of China. J. Med. Virol. 87, 1641–1648.
Kimble, J.B., Sorrell, E., Shao, H., Martin, P.L., Perez, D.R., 2011. Compatibility of H9N2
avian inﬂuenza surface genes and 2009 pandemic H1N1 internal genes for
transmission in the ferret model. Proc. Natl. Acad. Sci. USA 108, 12084–12088.
Li, X., Shi, J., Guo, J., Deng, G., Zhang, Q., Wang, J., He, X., Wang, K., Chen, J., Li, Y., Fan,
J., Kong, H., Gu, C., Guan, Y., Suzuki, Y., Kawaoka, Y., Liu, L., Jiang, Y., Tian, G., Li, Y.,
Bu, Z., Chen, H., 2014. Genetics, receptor binding property, and transmissibility
in mammals of naturally isolated H9N2 Avian Inﬂuenza viruses. PLoS Pathog.
10, e1004508.
Maher, J.A., DeStefano, J., 2004. The ferret: an animal model to study inﬂuenza
virus. Lab. Anim. 33, 50–53.
Matrosovich, M.N., Krauss, S., Webster, R.G., 2001. H9N2 inﬂuenza A viruses from
poultry in Asia have human virus-like receptor speciﬁcity. Virology 281,
156–162.Novel Swine-Origin Inﬂuenza, A.V.I.T., Dawood, F.S., Jain, S., Finelli, L., Shaw, M.W.,
Lindstrom, S., Garten, R.J., Gubareva, L.V., Xu, X., Bridges, C.B., Uyeki, T.M., 2009.
Emergence of a novel swine-origin inﬂuenza A (H1N1) virus in humans. N.
Engl. J. Med. 360, 2605–2615.
Ohuchi, M., Feldmann, A., Ohuchi, R., Klenk, H.D., 1995. Neuraminidase is essential
for fowl plague virus hemagglutinin to show hemagglutinating activity. Virol-
ogy 212, 77–83.
Organization, W.H., 2015. AntigenIc and Genetic Characteristics of Zoonotic Inﬂu-
enza Viruses and Development of Candidate Vaccine Viruses for Pandemic
Preparedness. 〈http://www.who.int/inﬂuenza/vaccines/virus/201509_zoonotic_
vaccinevirusupdate.pdf?ua¼1〉.
Pawar, S.D., Tandale, B.V., Raut, C.G., Parkhi, S.S., Barde, T.D., Gurav, Y.K., Kode, S.S.,
Mishra, A.C., 2012. Avian inﬂuenza H9N2 seroprevalence among poultry
workers in Pune, India, 2010. PLoS One 7, e36374.
Pham, V.L., Nakayama, M., Itoh, Y., Ishigaki, H., Kitano, M., Arikata, M., Ishida, H.,
Kitagawa, N., Shichinohe, S., Okamatsu, M., Sakoda, Y., Tsuchiya, H., Nakamura,
S., Kida, H., Ogasawara, K., 2013. Pathogenicity of pandemic H1N1 inﬂuenza A
virus in immunocompromised cynomolgus macaques. PloS one 8, e75910.
Shtyrya, Y.A., Mochalova, L.V., Bovin, N.V., 2009. Inﬂuenza virus neuraminidase:
structure and function. Acta Nat. 1, 26–32.
Sorrell, E.M., Wan, H., Araya, Y., Song, H., Perez, D.R., 2009. Minimal molecular
constraints for respiratory droplet transmission of an avian-human H9N2
inﬂuenza A virus. Proc. Natl. Acad. Sci. USA 106, 7565–7570.
Sun, J., Braciale, T.J., 2013. Role of T cell immunity in recovery from inﬂuenza virus
infection. Curr. Opin. Virol. 3, 425–429.
Sun, Y., Pu, J., Jiang, Z., Guan, T., Xia, Y., Xu, Q., Liu, L., Ma, B., Tian, F., Brown, E.G., Liu,
J., 2010. Genotypic evolution and antigenic drift of H9N2 inﬂuenza viruses in
China from 1994 to 2008. Vet. Microbiol. 146, 215–225.
Suzuki, T., Takahashi, T., Guo, C.T., Hidari, K.I., Miyamoto, D., Goto, H., Kawaoka, Y.,
Suzuki, Y., 2005. Sialidase activity of inﬂuenza a virus in an endocytic pathway
enhances viral replication. J. Virol. 79, 11705–11715.
Uhlendorff, J., Matrosovich, T., Klenk, H.D., Matrosovich, M., 2009. Functional sig-
niﬁcance of the hemadsorption activity of inﬂuenza virus neuraminidase and
its alteration in pandemic viruses. Arch. Virol. 154, 945–957.
Wan, H., Perez, D.R., 2007. Amino acid 226 in the hemagglutinin of H9N2 inﬂuenza
viruses determines cell tropism and replication in human airway epithelial
cells. J. Virol. 81, 5181–5191.
Wan, H., Sorrell, E.M., Song, H., Hossain, M.J., Ramirez-Nieto, G., Monne, I., Stevens,
J., Cattoli, G., Capua, I., Chen, L.M., Donis, R.O., Busch, J., Paulson, J.C., Brockwell,
C., Webby, R., Blanco, J., Al-Natour, M.Q., Perez, D.R., 2008. Replication and
transmission of H9N2 inﬂuenza viruses in ferrets: evaluation of pandemic
potential. PLoS One 3, e2923.
Wang, M., Fu, C.X., Zheng, B.J., 2009. Antibodies against H5 and H9 avian inﬂuenza
among poultry workers in China. N. Engl. J. Med. 360, 2583–2584.
Yu, H., Zhou, Y.J., Li, G.X., Ma, J.H., Yan, L.P., Wang, B., Yang, F.R., Huang, M., Tong, G.
Z., 2011. Genetic diversity of H9N2 inﬂuenza viruses from pigs in China: a
potential threat to human health? Vet. Microbiol. 149, 254–261.
